OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become ...

OpenAI is putting its focus on AI infrastructure with Stargate at a time when rivals like China's DeepSeek are closing the ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...

WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...

Wednesday on the RealClearPolitics podcast, Andrew Walworth, Tom Bevan, and Carl Cannon discussed President Trump introducing ...

Elon Musk “very much” overstepped his bounds when he criticized a $500 billion artificial intelligence project touted by ...

Welcome to The Hill’s Technology newsletter {beacon} Technology Technology   The Big Story Stargate criticism tests Musk ...

President Donald Trump on Thursday shrugged off an ugly back-and-forth between tech CEOs Elon Musk and Sam Altman that pitted one of Trump’s most visible lieutenants against a key participant in a ...